Home Newsfeeds Meta CFO Says Co. Is Shifting To More Cost-Efficient Data Center Architecture That Can Support Both AI, Non-AI Workloads

News

Meta CFO Says Co. Is Shifting To More Cost-Efficient Data Center Architecture That Can Support Both AI, Non-AI Workloads

-Reuters

byMichael Horton

February 1, 2023

1 minute read

-Reuters

Moderna Announces New England Journal Of Medicine Publication Of Phase 3 Clinical Safety And Efficacy Data For MRNA-1345, The Company’s Investigational Respiratory Syncytial Virus Vaccine

By Benzinga Newsdesk

December 15, 9:05 AM

Moderna, Inc. (NASDAQ:MRNA) today announced the publication of positive Phase 3 clinical study results evaluating mRNA-1345, its vaccine candidate for respiratory syncytial virus (RSV), in The New England Journal of

MRNA

Ollie’s Bargain Outlet Plummets After Q3 Miss, FY22 Outlook Cut

By Shivani Kumaresan

December 7, 9:48 AM

Ollie’s Bargain Outlet Holdings Inc (NASDAQ:OLLI) reported third-quarter FY22 sales growth of 9% year-on-year to $418.07 million, missing the consensus of…

OLLI

JMP Securities Maintains Market Outperform on Root, Lowers Price Target to $20

By Benzinga Newsdesk

January 17, 8:44 AM

JMP Securities analyst Matthew Carletti maintains Root (NASDAQ:ROOT) with a Market Outperform and lowers the price target from $25 to $20.

ROOT

Lucy Scientific Discovery Plans To Manufacture Cocaine And Heroin To Supply Harm Reduction Programs Globally

By Vuk Zdinjak

February 17, 8:46 AM

Lucy Scientific Discovery Inc. (NASDAQ: LSDI) an early-stage psychedelics manufacturing company, has filed an amendment to its current Dealer’s License with Health Canada to add cocaine and heroin, among others to the list of approved substances t

LSDI

Meta CFO Says Co. Is Shifting To More Cost-Efficient Data Center Architecture That Can Support Both AI, Non-AI Workloads

Related Posts

Moderna Announces New England Journal Of Medicine Publication Of Phase 3 Clinical Safety And Efficacy Data For MRNA-1345, The Company’s Investigational Respiratory Syncytial Virus Vaccine

Ollie’s Bargain Outlet Plummets After Q3 Miss, FY22 Outlook Cut

JMP Securities Maintains Market Outperform on Root, Lowers Price Target to $20

Lucy Scientific Discovery Plans To Manufacture Cocaine And Heroin To Supply Harm Reduction Programs Globally